BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37068442)

  • 1. IFN-β activates cytotoxic function of human natural killer cells toward IL-27 and poly(I:C) stimulated PC3 and DU145 cells.
    Kourko O; Hawke LG; Ormiston ML; Gee K
    Cell Immunol; 2023 May; 387():104718. PubMed ID: 37068442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 3. Poly(I:C)-Mediated Death of Human Prostate Cancer Cell Lines Is Induced by Interleukin-27 Treatment.
    Kourko O; Smyth R; Cino D; Seaver K; Petes C; Eo SY; Basta S; Gee K
    J Interferon Cytokine Res; 2019 Aug; 39(8):483-494. PubMed ID: 31009295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-1BB antibody enhances cytotoxic activity of natural killer cells against prostate cancer cells via NKG2D agonist combined with IL-27.
    Li Z; Simin L; Jian K; Xin G; Youlin K
    Immunotherapy; 2022 Sep; 14(13):1043-1053. PubMed ID: 35852136
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells.
    Sakellariou C; Elhage O; Papaevangelou E; Giustarini G; Esteves AM; Smolarek D; Smith RA; Dasgupta P; Galustian C
    BJU Int; 2020 Jan; 125(1):89-102. PubMed ID: 31392791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UV Light-inactivated HSV-1 Stimulates Natural Killer Cell-induced Killing of Prostate Cancer Cells.
    Samudio I; Hofs E; Cho B; Li M; Bolduc K; Bu L; Liu G; Lam V; Rennie P; Jia W; Elisia I; Krystal G
    J Immunother; 2019 Jun; 42(5):162-174. PubMed ID: 30933043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diesel exhaust particles modify natural killer cell function and cytokine release.
    Müller L; Chehrazi CV; Henderson MW; Noah TL; Jaspers I
    Part Fibre Toxicol; 2013 Apr; 10():16. PubMed ID: 23618096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between TLR3 and IL-18 promotes IFN-γ dependent TRAIL expression in human liver NK cells.
    Tu Z; Hamalainen-Laanaya HK; Crispe IN; Orloff MS
    Cell Immunol; 2011; 271(2):286-91. PubMed ID: 21802664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
    Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
    Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
    Mori S; Jewett A; Murakami-Mori K; Cavalcanti M; Bonavida B
    Cancer Immunol Immunother; 1997 Jul; 44(5):282-90. PubMed ID: 9247563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration.
    Ridge SM; Bhattacharyya D; Dervan E; Naicker SD; Burke AJ; Murphy JM; O'leary K; Greene J; Ryan AE; Sullivan FJ; Glynn SA
    Int J Cancer; 2018 May; 142(10):2056-2067. PubMed ID: 29266277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells.
    Choi YH; Lim EJ; Kim SW; Moon YW; Park KS; An HJ
    J Immunother Cancer; 2019 Jul; 7(1):168. PubMed ID: 31277710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate carcinoma cells LNCaP and glucan cooperate in induction of cytokine synthesis by dendritic cells: effect on natural killer cells and CD4+ lymphocytes activation.
    Donini M; Marongiu L; Fontana E; Dusi S
    Prostate; 2012 Apr; 72(5):566-76. PubMed ID: 21796650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity.
    Hu W; Zheng RR; Cui HX; Yue D; Wang Y; Jiang YH
    Asian J Androl; 2012 Sep; 14(5):695-702. PubMed ID: 22902909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
    Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
    Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells.
    González-Ochoa S; Tellez-Bañuelos MC; Méndez-Clemente AS; Bravo-Cuellar A; Hernández Flores G; Palafox-Mariscal LA; Haramati J; Pedraza-Brindis EJ; Sánchez-Reyes K; Ortiz-Lazareno PC
    J Immunol Res; 2022; 2022():1810804. PubMed ID: 35465350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells.
    Kajitani K; Tanaka Y; Arihiro K; Kataoka T; Ohdan H
    Breast Cancer Res Treat; 2012 Jul; 134(1):139-55. PubMed ID: 22261932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.